This brand name is authorized in United States
The drug LAMPIT contains one active pharmaceutical ingredient (API):
|
1
Nifurtimox
UNII M84I3K7C2O - NIFURTIMOX
|
|
Nifurtimox is an antiprotozoal drug. It is used in pediatric patients for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi. Nifurtimox exposure-response relationships and the time course of pharmacodynamics response are unknown. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| LAMPIT Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 50419-750, 50419-751 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
